Results 101 to 110 of about 49,783 (286)
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate +6 more
wiley +1 more source
Management of macular edema due to central retinal vein occlusion – The role of aflibercept
Central retinal vein occlusion (CRVO) can cause vision loss. The pathogenesis of CRVO involves a thrombus formation leading to increased retinal capillary pressure, increased vascular permeability, and possibly retinal neovascularization. Vision loss due
W. Rhoades, D. Dickson, Q. Nguyen, D. Do
semanticscholar +1 more source
Retinal Artery and Vein Occlusions Successfully Treated with Hyperbaric Oxygen [PDF]
We present six cases of central retinal artery occlusion (CRAO) and central retinal vein occlusion (CRVO) that we recently treated with hyperbaric oxygen (HBO2).
Cooper, Jeffrey S., Johnson, Daniel R.
core
Intravitreal Pegaptanib in Ischemic CRVO Refractory Exudative Macular Detachment [PDF]
Recent literature data reported evidence of the visual and/or anatomical benefits of all clinically available anti-VEGF drugs for the treatment of macular edema (ME) following Central Retinal Vein Occlusion (CRVO), up to 1-year followup.
CILLINO, Giovanni, CILLINO, Salvatore
core +2 more sources
Abstract Purpose To investigate the role of spectral domain optical coherence tomography (SD‐OCT)‐based biomarkers in predicting treatment response of macular oedema (MO) secondary to retinal vein occlusion (RVO) to anti‐vascular endothelial growth factor (VEGF) therapy.
Ken K. Tsang +9 more
wiley +1 more source
IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion
Retinal vein occlusion (RVO) is a common retinal vascular disease. RVO may be complicated by pronounced ischemia that often leads to severe loss of visual function.
Lasse Jørgensen Cehofski +7 more
semanticscholar +1 more source
Norio Okamoto, Chota Matsumoto, Yoshikazu Shimomura Department of Ophthalmology, Kinki University Faculty of Medicine, Osakasayama City, Osaka, Japan Background: There are some cases that reported central retinal vein occlusion accompanied by ciliary ...
Okamoto N, Matsumoto C, Shimomura Y
doaj
Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]
Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo +6 more
core +1 more source
Abstract Purpose This study assesses the PAUL® glaucoma implant (PGI) in primary open angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG) after failed glaucoma surgery. Given PEXG's more aggressive nature, limited research exists on PGI outcomes in this subgroup. This study aims to compare PGI's efficacy and safety in both conditions. Methods A
Constance Liegl +8 more
wiley +1 more source
PURPOSE To investigate the relationship between best-corrected visual acuity (BCVA) and the foveal avascular zone (FAZ) in patients with central retinal vein occlusion (CRVO) evaluated with optical coherence angiography (OCT-A). METHODS The study was a
Manuel Casselholmde Salles +3 more
semanticscholar +1 more source

